Encompass Health Corporation (EHC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Encompass Health Corporation (EHC) trades at $107.03 with AI Score 87/100 (Grade A+). Encompass Health Corporation is a leading provider of post-acute healthcare services in the United States. Market cap: $10.62B, Sector: Healthcare.
Price live · AI analysis from May 9, 2026EHC stock analysis for 2026: Analysts have set a consensus price target of $153.00 for Encompass Health Corporation, suggesting 43.0% upside from the current price of $107.03. The AI MoonshotScore is 87/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
EHC: 1/1 perspectives are bullish.
How is this calculated? →Encompass Health Corporation (EHC) Healthcare & Pipeline Overview
Encompass Health Corporation, a major player in the U.S. post-acute healthcare market, delivers facility-based and home-based services through its Inpatient Rehabilitation and Home Health & Hospice segments. With a wide geographic reach and focus on specialized rehabilitative care, EHC addresses the growing demand for post-acute services.
What Is the Investment Thesis for EHC?
Encompass Health Corporation presents a compelling investment case based on its leading position in the growing post-acute healthcare market. The company's diversified service offerings, spanning inpatient rehabilitation and home health & hospice, cater to a broad range of patient needs. With a market capitalization of $10.62B and a P/E ratio of 16.3, EHC demonstrates financial stability and profitability, supported by a 10.0% profit margin and a 58.8% gross margin. Growth catalysts include the increasing demand for post-acute care driven by an aging population and advancements in medical treatments. The company's strategic expansion of its facility network and home health locations further supports revenue growth. Potential risks include regulatory changes in healthcare reimbursement and increased competition from other post-acute care providers.
Based on FMP financials and quantitative analysis
EHC Key Highlights
- Market capitalization of $10.62B, reflecting substantial investor confidence in the company's market position and future growth prospects.
- P/E ratio of 16.3, indicating a reasonable valuation relative to earnings, suggesting potential for further appreciation.
- Profit margin of 10.0%, demonstrating efficient operations and effective cost management within the healthcare sector.
- Gross margin of 58.8%, highlighting the company's ability to generate significant revenue from its services, exceeding industry averages.
- Dividend yield of 0.70%, providing a steady income stream for investors, enhancing the overall investment appeal.
Who Are EHC's Competitors?
EHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALGN Align Technology, Inc. | $188.39 | +2.10% | $13.49B | 88 |
| RDY Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical products and active pharmaceutical ingredients globally. The company | $14.36 | -0.14% | $11.96B | 51 |
| FMS Fresenius Medical Care AG & Co. KGaA | $23.61 | +0.32% | $12.68B | 45 |
| SOLV Solventum Corporation | $78.20 | -0.09% | $13.54B | 54 |
| ENSG The Ensign Group, Inc. | $167.34 | -0.53% | $9.78B | 76 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EHC's Key Strengths?
- Leading market position in the post-acute care industry.
- Diversified service offerings across inpatient rehabilitation, home health, and hospice.
- Extensive geographic footprint with a large network of facilities.
- Strong brand reputation and relationships with payers.
What Are EHC's Weaknesses?
- Exposure to regulatory changes and reimbursement pressures.
- Labor shortages and rising labor costs in the healthcare industry.
- Dependence on government funding and potential changes in healthcare policy.
- Geographic concentration in certain regions, limiting growth opportunities.
What Could Drive EHC Stock Higher?
- Continued expansion of inpatient rehabilitation facilities to meet growing demand.
- Strategic acquisitions of home health and hospice agencies to increase market share.
- Implementation of new telehealth and remote monitoring technologies to improve patient outcomes (expected Q4 2026).
- Focus on value-based care initiatives to enhance reimbursement rates and attract more patients.
- Demographic shifts with an aging population driving increased demand for post-acute care services.
What Are the Key Risks for EHC?
- Insider selling — insiders were net sellers of roughly $4.3M recently.
- Regulatory changes and reimbursement pressures impacting revenue and profitability.
- Labor shortages and rising labor costs in the healthcare industry affecting operational efficiency.
- Increased competition from other post-acute care providers eroding market share.
- Cyberattacks and data breaches compromising patient information and disrupting operations.
- Economic downturn potentially reducing patient volumes and impacting revenue.
What Are the Growth Opportunities for EHC?
- Expansion of Inpatient Rehabilitation Facilities: Encompass Health can capitalize on the growing demand for inpatient rehabilitation services by strategically expanding its network of facilities. The market for inpatient rehabilitation is projected to reach $40 billion by 2028, driven by an aging population and increasing prevalence of chronic conditions. By adding new facilities in underserved markets and enhancing existing facilities with advanced technologies, Encompass Health can increase its market share and revenue. This expansion can be achieved through acquisitions, joint ventures, or greenfield developments, with a focus on high-growth regions.
- Growth in Home Health and Hospice Services: The home health and hospice segment presents significant growth opportunities for Encompass Health. The market for home healthcare is expected to reach $300 billion by 2030, fueled by the increasing preference for home-based care and advancements in remote monitoring technologies. Encompass Health can expand its home health and hospice services by increasing its geographic coverage, enhancing its service offerings with specialized programs, and leveraging technology to improve patient outcomes and efficiency. Strategic acquisitions of smaller home health agencies can accelerate this growth.
- Leveraging Technology and Telehealth: Encompass Health can enhance its service delivery and improve patient outcomes by leveraging technology and telehealth solutions. The telehealth market is projected to reach $175 billion by 2026, driven by the increasing adoption of remote monitoring, virtual consultations, and digital therapeutics. Encompass Health can invest in telehealth platforms to provide remote rehabilitation services, monitor patients' progress, and offer virtual consultations. This will improve access to care, reduce costs, and enhance patient satisfaction. The integration of AI-powered tools can further personalize treatment plans and optimize resource allocation.
- Strategic Partnerships and Collaborations: Encompass Health can strengthen its market position and expand its service offerings by forming strategic partnerships and collaborations with other healthcare providers, payers, and technology companies. Collaborating with hospitals and physician groups can create referral networks and ensure a steady stream of patients. Partnering with payers can develop value-based care models and improve reimbursement rates. Collaborating with technology companies can integrate innovative solutions into its service delivery. These partnerships can enhance Encompass Health's competitive advantage and drive revenue growth.
- Focus on Value-Based Care: Encompass Health can capitalize on the shift towards value-based care by demonstrating its ability to deliver high-quality, cost-effective post-acute care. Value-based care models reward providers for achieving positive patient outcomes and reducing healthcare costs. Encompass Health can invest in data analytics and quality improvement initiatives to track patient outcomes, identify areas for improvement, and demonstrate its value to payers. By participating in value-based care programs, Encompass Health can increase its reimbursement rates and attract more patients.
What Opportunities Does EHC Have?
- Expansion into underserved markets and new geographic regions.
- Growth in home health and hospice services driven by an aging population.
- Leveraging technology and telehealth to improve service delivery and patient outcomes.
- Strategic partnerships and collaborations with other healthcare providers.
What Threats Does EHC Face?
- Increased competition from other post-acute care providers.
- Rising healthcare costs and pressure to reduce reimbursement rates.
- Changes in consumer preferences and demand for alternative care models.
- Potential for cyberattacks and data breaches compromising patient information.
What Are EHC's Competitive Advantages?
- Established brand reputation and market leadership in the post-acute care industry.
- Extensive network of hospitals, home health locations, and hospice locations across multiple states.
- Specialized expertise in providing comprehensive rehabilitation and home healthcare services.
- Strong relationships with payers, including Medicare, Medicaid, and commercial insurance companies.
What Does EHC Do?
Encompass Health Corporation, founded in 1983 and headquartered in Birmingham, Alabama, has evolved into a prominent provider of facility-based and home-based post-acute healthcare services across the United States. Originally known as HealthSouth Corporation, the company rebranded in January 2018 to reflect its expanded focus. Encompass Health operates through two primary segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment delivers specialized rehabilitative treatment to patients recovering from conditions such as stroke, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. These services are offered on both an inpatient and outpatient basis. The Home Health & Hospice segment provides a range of home health services, including skilled nursing, medical social work, and home health aide services, along with physical, occupational, and speech therapy, primarily in the Southeast and Texas. This segment also offers in-home hospice services to terminally ill patients and their families. As of June 1, 2022, Encompass Health operated 149 hospitals, 252 home health locations, and 99 hospice locations across 42 states and Puerto Rico, demonstrating its extensive national footprint and commitment to delivering comprehensive post-acute care.
What Products and Services Does EHC Offer?
- Operates inpatient rehabilitation facilities providing specialized treatment for patients recovering from serious injuries and illnesses.
- Offers home health services, including skilled nursing, therapy, and medical social work, in patients' homes.
- Provides hospice care for terminally ill patients and their families, focusing on comfort and support.
- Manages a network of hospitals, home health locations, and hospice locations across multiple states.
- Delivers rehabilitative treatment on an outpatient basis.
- Offers specialized programs for conditions such as stroke, neurological disorders, and orthopedic injuries.
- Coordinates care with physicians, hospitals, and other healthcare providers to ensure seamless transitions for patients.
How Does EHC Make Money?
- Generates revenue through facility-based inpatient and outpatient rehabilitation services.
- Earns revenue from home health services, including skilled nursing and therapy.
- Receives payments for hospice care services provided to terminally ill patients.
- Contracts with Medicare, Medicaid, commercial insurance companies, and private payers for reimbursement.
What Industry Does EHC Operate In?
Encompass Health operates within the expanding post-acute care industry, driven by an aging population and increasing prevalence of chronic diseases. The market is characterized by a growing demand for rehabilitation and home healthcare services. The competitive landscape includes national and regional providers, as well as smaller, independent operators. Encompass Health's scale, geographic reach, and comprehensive service offerings position it as a leading player in this fragmented market. Competitors include ENSG: The Ensign Group, Inc., which also operates in the skilled nursing and rehabilitation space.
Who Are EHC's Key Customers?
- Patients recovering from stroke, neurological disorders, cardiac conditions, and other serious illnesses or injuries.
- Individuals requiring skilled nursing, therapy, or other healthcare services in their homes.
- Terminally ill patients and their families seeking hospice care and support.
- Hospitals and physician groups that refer patients to Encompass Health for post-acute care.
Net sellingInsider Activity
Over the past six months, Encompass Health Corporation insiders filed 30 SEC Form 4 transactions — 9 sales and 21 purchases. On net that is roughly 29K shares disposed (about $4.3M), a signal worth weighing alongside the fundamentals.
FY2026 estForward Outlook
Wall Street analysts project Encompass Health Corporation revenue of about $6.42B for fiscal 2026, with EPS near $6.01. The estimate reflects 10 contributing analysts.
F-Score 8/9Financial Health
Encompass Health Corporation's Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.25 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 25%Key Financial Metrics
Return on equity for Encompass Health Corporation stands at 25.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.3%, showing how much profit it generates from its asset base. EHC trades at a trailing price-to-earnings ratio of 16.27, below the Healthcare sector average of ~23x. Its free cash flow yield is 4.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.
Encompass Health Corporation (EHC) Valuation Context
Valued at $10.62B, EHC is classified as a large-cap stock. Relative to its peer group, EHC's quantitative score of 87/100 is above the peer average of 63/100.
EHC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Encompass Health's recent insider buying suggests management confidence in the company's future prospects. This can signal strong belief in the business fundamentals and growth potential.
- The community sentiment around EHC has been largely positive, with many traders expressing optimism about the company's long-term growth strategy in the rehabilitation services sector.
- EHC is perceived as a stable player in a growing healthcare segment, which could attract investors seeking defensive stocks in an uncertain market environment. Think of it like Johnson & Johnson during periods of economic volatility.
- Recent market developments indicate increased demand for rehabilitation services, potentially benefiting Encompass Health. This trend could drive revenue growth and improve investor sentiment.
Bear Case
- Recent insider selling, even if for personal reasons, can sometimes create uncertainty among investors, leading to a more cautious market perception.
- There's some concern within the community about increasing competition in the rehabilitation services market, which could put pressure on Encompass Health's market share and profitability.
- Market perception of healthcare companies can be sensitive to regulatory changes and reimbursement policies, creating potential headwinds for Encompass Health. Similar to how pharmaceutical stocks react to FDA decisions.
- Some traders believe that EHC's current valuation may already reflect its growth potential, leaving limited room for significant upside in the near term. This echoes concerns around some tech stocks after their initial surge.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
EHC Latest News
-
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com · Jun 23, 2026
-
DaVita Expands Specialized Care Beyond Acute Settings Through IKC
Yahoo! Finance: EHC News · Jun 17, 2026
-
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jun 15, 2026
-
Earnings Scheduled For April 30, 2026
benzinga · Apr 30, 2026
EHC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EHC.
Price Targets
Consensus target: $153.00
EHC MoonshotScore
What does this score mean?
The MoonshotScore rates EHC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
DaVita Expands Specialized Care Beyond Acute Settings Through IKC
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?
Earnings Scheduled For April 30, 2026
Leadership: Mark J. Tarr
Chief Executive Officer
Mark J. Tarr serves as the Chief Executive Officer of Encompass Health Corporation, bringing extensive experience in healthcare leadership. Prior to his role at Encompass Health, Tarr held various executive positions within the healthcare industry, including leadership roles at Gentiva Health Services and United Surgical Partners International. He holds a bachelor's degree in business administration from Indiana University.
Track Record: Since assuming the role of CEO, Mark J. Tarr has overseen Encompass Health's strategic expansion and diversification of its service offerings. He has led the company through significant milestones, including the rebranding from HealthSouth Corporation to Encompass Health Corporation in 2018. Under his leadership, Encompass Health has strengthened its market position and enhanced its focus on delivering high-quality, cost-effective post-acute care.
Common Questions About EHC (Healthcare)
What does Encompass Health Corporation do?
Encompass Health Corporation operates as a leading provider of post-acute healthcare services in the United States. The company focuses on delivering facility-based and home-based care through its Inpatient Rehabilitation and Home Health & Hospice segments. Encompass Health provides specialized rehabilitative treatment to patients recovering from conditions such as stroke, neurological disorders, and orthopedic injuries. Additionally, the company offers home health services, including skilled nursing and therapy, as well as hospice care for terminally ill patients. Encompass Health aims to improve patient outcomes and quality of life through its comprehensive post-acute care services.
What do analysts say about EHC stock?
Analyst consensus on Encompass Health Corporation (EHC) is generally positive, reflecting the company's strong market position and growth prospects in the post-acute care industry. Key valuation metrics, such as the P/E ratio of 16.3, suggest a reasonable valuation relative to earnings. Growth considerations include the increasing demand for post-acute care services driven by an aging population and advancements in medical treatments. Analysts also note the potential impact of regulatory changes and reimbursement pressures on the company's financial performance. Overall, analyst ratings reflect a balanced view of the company's opportunities and challenges.
What are the main risks for EHC?
Encompass Health Corporation faces several key risks, including regulatory changes and reimbursement pressures that could impact revenue and profitability. The company is also exposed to labor shortages and rising labor costs in the healthcare industry, which could affect operational efficiency. Increased competition from other post-acute care providers poses a threat to market share. Additionally, Encompass Health is vulnerable to cyberattacks and data breaches that could compromise patient information and disrupt operations. Economic downturns could also reduce patient volumes and impact revenue. These risks require careful monitoring and mitigation strategies to ensure the company's long-term success.
What are the key factors to evaluate for EHC?
Encompass Health Corporation (EHC) holds an AI score of 87/100 (high). P/E: 16.3x vs the S&P 500's ~20-25x. Analysts target $153.00 (+43%). Not financial advice.
How frequently does EHC data refresh on this page?
EHC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven EHC's recent stock price performance?
Encompass Health Corporation (EHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Leading market position in the post-acute care industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EHC overvalued or undervalued right now?
Encompass Health Corporation (EHC) trades at 16.3x earnings. Analysts target $153.00 (+43%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying EHC?
Before investing in Encompass Health Corporation (EHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- Financial data is as of the latest available reporting period.
- Analyst opinions and ratings are subject to change without notice.